Number of shares and voting rights as at 31/10/2017
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st October.
Free allocation of stock warrants
Following the approval by the shareholders of the 3rd resolution at the Shareholders' Meeting on 26/10/2017, the company issued redeemable share warrants (BSAR C).
General Meeting of shareholders on 26/10/2017
- Approval of all Resolutions
On October 26, 2017 (by 2nd call), under the chairmanship of Pierre Catlin, the Extraordinary General Meeting of the Company gathered its shareholders representing 37,956,617 shares (present, represented or postal votes), corresponding to 24.95% of the capital.
Number of shares and voting rights as at 30/09/2017
Europlasma declares the number of voting rights and shares comprising its share capital as at 30 September.
ERRATUM
The 3rd resolution regarding the conditions of issue and subscription of the BSAR C as mentioned in the text of the resolutions addressed to the registered shareholders contained material errors.
Review of the 2014-2017 Strategy and growth outlook
After 3 years of efforts, 2017 saw the industrial and commercial achievements of innovative application of the plasma torch in various projects that fully meet current and future environmental and energy challenges.
Press release
Delivery of the plasma facility for the treatment of low-level radioactive waste in Bulgaria